The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 06, 2016

Filed:

Jun. 12, 2014
Applicants:

William E. Sweeney, Waukesha, WI (US);

Ellis D. Avner, Milwaukee, WI (US);

Richard J. Roman, Brookfield, WI (US);

Inventors:

William E. Sweeney, Waukesha, WI (US);

Ellis D. Avner, Milwaukee, WI (US);

Richard J. Roman, Brookfield, WI (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5375 (2006.01); A61K 31/155 (2006.01); A61K 31/18 (2006.01); A61K 31/20 (2006.01); A61K 31/201 (2006.01); A61K 31/202 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5375 (2013.01); A61K 31/155 (2013.01); A61K 31/18 (2013.01); A61K 31/20 (2013.01); A61K 31/201 (2013.01); A61K 31/202 (2013.01);
Abstract

The present invention provides a method for preferentially reducing the proliferation of cystic epithelial cells in the kidney or bile duct in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to preferentially reduce the proliferation of cystic epithelial cells over normal epithelial cells such as tubule epithelial cells in the kidney or bile duct. The present invention also provides a method for preventing or treating autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), ARPKD associated congenital hepatic fibrosis, ARPKD associated Caroli's disease, or cholangiocarcinoma in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to prevent or treat the disease.


Find Patent Forward Citations

Loading…